Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Orlando Musso

Showing results (21-30 of 27) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 27 results.
Hepatology (Baltimore, Md.)|March 31, 2023
Hepatocellular carcinomas, exhibiting intratumor fibrosis, express cancer-specific extracellular matrix remodeling and WNT/TGFB signatures, associated with poor outcomeRomain Desert, Wei Chen, Xiaodong Ge, et al.
Hepatology (Baltimore, Md.)|May 13, 2017
Human hepatocellular carcinomas with a periportal phenotype have the lowest potential for early recurrence after curative resectionRomain Désert, Florian Rohart, Frédéric Canal, et al.
Hepatology Communications|November 3, 2021
Role of Hepatocyte-Derived Osteopontin in Liver CarcinogenesisRomain Desert, Xiaodong Ge, Zhuolun Song, et al.
Hepatology (Baltimore, Md.)|October 24, 2006
Upregulation of the tumor suppressor gene menin in hepatocellular carcinomas and its significance in fibrogenesisPierre J Zindy, Annie L'Helgoualc'h, Dominique Bonnier, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|July 8, 2026
Catecholamines Activate a Tumour Progression Program in Differentiated Tumour HepatocytesElise Lelou, Claudine Rauch, Hélène Dubois-Pot-Schneider, et al.
Oncotarget|May 19, 2016
De novo HAPLN1 expression hallmarks Wnt-induced stem cell and fibrogenic networks leading to aggressive human hepatocellular carcinomasSihem Mebarki, Romain Désert, Laurent Sulpice, et al.
Cell Death & Disease|November 17, 2025
PPARγ, a key modulator of metabolic reprogramming, stemness and chemoresistance associated with retrodifferentiation in human hepatocellular carcinomasYoann Daniel, Claudine Rauch, Lucille Moutaux, et al.
Pageof 3

Showing results (21-30 of 27) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 27 results.
Hepatology (Baltimore, Md.)|March 31, 2023
Hepatocellular carcinomas, exhibiting intratumor fibrosis, express cancer-specific extracellular matrix remodeling and WNT/TGFB signatures, associated with poor outcomeRomain Desert, Wei Chen, Xiaodong Ge, et al.
Hepatology (Baltimore, Md.)|May 13, 2017
Human hepatocellular carcinomas with a periportal phenotype have the lowest potential for early recurrence after curative resectionRomain Désert, Florian Rohart, Frédéric Canal, et al.
Hepatology Communications|November 3, 2021
Role of Hepatocyte-Derived Osteopontin in Liver CarcinogenesisRomain Desert, Xiaodong Ge, Zhuolun Song, et al.
Hepatology (Baltimore, Md.)|October 24, 2006
Upregulation of the tumor suppressor gene menin in hepatocellular carcinomas and its significance in fibrogenesisPierre J Zindy, Annie L'Helgoualc'h, Dominique Bonnier, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|July 8, 2026
Catecholamines Activate a Tumour Progression Program in Differentiated Tumour HepatocytesElise Lelou, Claudine Rauch, Hélène Dubois-Pot-Schneider, et al.
Oncotarget|May 19, 2016
De novo HAPLN1 expression hallmarks Wnt-induced stem cell and fibrogenic networks leading to aggressive human hepatocellular carcinomasSihem Mebarki, Romain Désert, Laurent Sulpice, et al.
Cell Death & Disease|November 17, 2025
PPARγ, a key modulator of metabolic reprogramming, stemness and chemoresistance associated with retrodifferentiation in human hepatocellular carcinomasYoann Daniel, Claudine Rauch, Lucille Moutaux, et al.
Pageof 3